Publication:
End-of-life discussions reduce the utilization of life-sustaining treatments during the last three months of life in cancer patients

Simple item page
cris.lastimport.scopus2026-02-26T16:02:18Z
dc.creatorChan, Shang-Yih
dc.creatorLai, Yun-Ju
dc.creatorChen, Yu-Yen
dc.creatorChiang, Shuo-Ju
dc.creatorTsai, Yi-Fan
dc.creatorHsu, Li-Fei
dc.creatorChuang, Pei-Hung
dc.creatorChen, Chu-Chieh
dc.creatorYen, Yung-Feng
dc.date2022-05-06
dc.date.accessioned2023-05-03T02:31:22Z
dc.date.accessioned2025-07-28T15:04:46Z
dc.date.available2023-05-03T02:31:22Z
dc.date.issued2023-05-03T02:31:22Z
dc.description.abstractStudies to examine the impact of end-of-life (EOL) discussions on the utilization of life-sustaining treatments near death are limited and have inconsistent findings. This nationwide population-based cohort study determined the impact of EOL discussions on the utilization of life-sustaining treatments in the last three months of life in Taiwanese cancer patients. From 2012 to 2018, this cohort study included adult cancer patients, which were confirmed by pathohistological reports. Life-sustaining treatments during the last three months of life included cardiopulmonary resuscitation, intubation, and defibrillation. EOL discussions in cancer patients were confirmed by their medical records. Association of EOL discussions with utilization of life-sustaining treatments were assessed using multiple logistic regression. Of 381,207 patients, the mean age was 70.5 years and 19.4% of the subjects received life-sustaining treatments during the last three months of life. After adjusting for other covariates, those who underwent EOL discussions were less likely to receive life-sustaining treatments during the last three months of life compared to those who did not (Adjusted odds ratio [AOR] 0.87; 95% confidence interval [CI] 0.85-0.89). Considering the type of treatments, EOL discussions correlated with a lower likelihood of receiving cardiopulmonary resuscitation (AOR= 0.45, 95% CI 0.43-0.47), endotracheal intubation (AOR= 0.92, 95%CI 0.90-0.95), and defibrillation (AOR= 0.54, 95%CI 0.49-0.59). Since EOL discussions are associated with less aggressive care, our study supports the importance of providing these discussions to cancer patients during the EOL treatment.
dc.format.extent142 bytes
dc.format.mimetypetext/html
dc.identifier.doi10.1038/s41598-022-11586-x
dc.identifier.issn2045-2322
dc.identifier.urihttps://ir.ntus.edu.tw/handle/987654321/65640
dc.languageen_US
dc.publisherBERLIN, GERMANY: NATURE PORTFOLIO
dc.relationSCIENTIFIC REPORTS, 12(1)
dc.titleEnd-of-life discussions reduce the utilization of life-sustaining treatments during the last three months of life in cancer patients
dc.typearticle
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
index.html
Size:
142 B
Format:
Hypertext Markup Language
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
702 B
Format:
Plain Text
Description:
Download

Collections

期刊論文